CardioComm Solutions IncOTC Pink - Current Information:EKGGFView on Canadian Exchange
- LAST PRICE0.0130
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0006/ 500
- Ask / Lots0.0200/ 100
- Open / Previous Close--- / 0.0130
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Nov 11, 2024
CardioComm Solutions Integrates ECG Technology into Sony's mSafety Platform, from 9:01AM ET on Monday Nov 11, 2024 by Dow Jones
9:01AM ET on Monday Nov 11, 2024 by Dow Jones
Oct 16, 2024
Canadian Investment Regulatory Organization Trade Resumption - EKG, from 1:46PM ET on Wednesday Oct 16, 2024 by Dow Jones
1:46PM ET on Wednesday Oct 16, 2024 by Dow JonesCardioComm Solutions Awarded Canadian Space Agency Contract for Design of Next Generation Connected Care Medical Module Prototype, from 1:30PM ET on Wednesday Oct 16, 2024 by Dow Jones
1:30PM ET on Wednesday Oct 16, 2024 by Dow JonesCanadian Investment Regulatory Organization Trading Halt - EKG, from 1:25PM ET on Wednesday Oct 16, 2024 by Dow Jones
1:25PM ET on Wednesday Oct 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CardioComm Solutions Inc | 3.9M | --- | --- |
Company Information
CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.
Contact Information
- Headquarters
- 18 Wynford Drive, Suite 305NORTH YORK, ON, Canada M3C 3S2
- Phone
- 416-977-9425
- Fax
- 416-977-9425
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9M |
|---|---|
Revenue (TTM) | $643.1K |
Shares Outstanding | 193.1M |
CardioComm Solutions Inc does not pay a dividend. | |
Beta | -0.19 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | --- |
Price/Sales (TTM) | 6.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -58.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
